iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by ArchPoint Investors

ArchPoint Investors reduced its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 16,000 shares of the financial services provider’s stock after selling 750 shares during the quarter. ArchPoint Investors’ holdings in iShares Biotechnology ETF were worth $2,115,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in IBB. HHM Wealth Advisors LLC increased its holdings in iShares Biotechnology ETF by 200.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 150 shares in the last quarter. VSM Wealth Advisory LLC acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $30,000. Bradley & Co. Private Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at about $32,000. Newbridge Financial Services Group Inc. purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at about $33,000. Finally, Hager Investment Management Services LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter worth approximately $34,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 5.4 %

Shares of NASDAQ:IBB opened at $117.16 on Monday. The company has a market capitalization of $5.28 billion, a price-to-earnings ratio of 24.21 and a beta of 0.84. The company has a 50 day moving average of $134.95 and a two-hundred day moving average of $138.05. iShares Biotechnology ETF has a 52-week low of $114.32 and a 52-week high of $150.57.

iShares Biotechnology ETF Increases Dividend

The company also recently declared a dividend, which was paid on Friday, March 21st. Investors of record on Tuesday, March 18th were issued a dividend of $0.1212 per share. This is a positive change from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date of this dividend was Tuesday, March 18th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.